1. Home
  2. WAY vs MMED Comparison

WAY vs MMED Comparison

Compare WAY & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waystar Holding Corp.

WAY

Waystar Holding Corp.

N/A

Current Price

$27.91

Market Cap

4.8B

Sector

N/A

ML Signal

N/A

Logo MiniMed Group Inc. Common Stock

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$18.16

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAY
MMED
Founded
1999
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.5B
IPO Year
2023
2025

Fundamental Metrics

Financial Performance
Metric
WAY
MMED
Price
$27.91
$18.16
Analyst Decision
Strong Buy
Buy
Analyst Count
23
16
Target Price
★ $34.09
$25.47
AVG Volume (30 Days)
2.0M
★ 15.3M
Earning Date
11-02-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 569.23
N/A
EPS
★ 0.43
N/A
Revenue
$1,099,278,000.00
★ $3,102,000,000.00
Revenue This Year
$17.00
$10.76
Revenue Next Year
$10.68
$8.51
P/E Ratio
$65.63
★ N/A
Revenue Growth
★ 16.50
14.25
52 Week Low
$17.26
$10.65
52 Week High
$37.71
$24.43

Technical Indicators

Market Signals
Indicator
WAY
MMED
Relative Strength Index (RSI) 54.64 43.90
Support Level $23.64 $16.55
Resistance Level $29.25 $20.88
Average True Range (ATR) 1.05 0.91
MACD -0.05 0.16
Stochastic Oscillator 59.45 57.03

Price Performance

Historical Comparison
WAY
MMED

About WAY Waystar Holding Corp.

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About MMED MiniMed Group Inc. Common Stock

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

Share on Social Networks: